NCT06290908 is a clinical trial of RPE-P/TLIF in Spinal Stenosis, sponsored by Wen-xi Sun.

Who is sponsoring NCT06290908?

NCT06290908 is sponsored by Wen-xi Sun.

What drugs are being tested in NCT06290908?

Interventions in NCT06290908: RPE-P/TLIF.

What condition does NCT06290908 study?

NCT06290908 studies Spinal Stenosis.

Is NCT06290908 still recruiting?

NCT06290908 is currently completed. Last updated 4 March 2024.

Last reviewed 2024-03-04 · How we verify

NCT06290908

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

RPE-P/TLIF for Lumbar Spinal Stenosis With Instability

Completed Last updated 4 March 2024

What this trial tests

trial testing RPE-P/TLIF in Spinal Stenosis in 26 participants. Completed in 1 February 2024.

Timeline

4 September 2018

Primary endpoint
30 April 2022

1 February 2024

Quick facts

Lead sponsor	Wen-xi Sun
Status	Completed
Study type	OBSERVATIONAL
Enrollment	26
Start date	4 September 2018
Primary completion	30 April 2022
Estimated completion	1 February 2024
Sites	1 location across China

Drugs / interventions tested

RPE-P/TLIF

Conditions studied

Spinal Stenosis — all drugs for Spinal Stenosis →

Sponsor

Wen-xi Sun

Who can join

Adults 18 to 80, any sex, with Spinal Stenosis. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

Objective To analyze the effectiveness and safety of robot-assisted percutaneous endoscopic posterior/transforaminal lumbar interbody fusion (RPE-P/TLIF) in the treatment of lumbar spinal stenosis with instability. Methods A single-center prospective study from September 2018 to April 2022, patients with lumbar spinal stenosis and instability who met the inclusion and exclusion criteria were treated with RPE-P/TLIF. Pain visual analog scale (VAS) was used to evaluate the degree of low back pain and lower limb pain before operation, 1 month, 6 months, 1 year after operation and at the final follow-up, and the Oswestry disability index (ODI) was used to evaluate the degree of lumbar spinal function. At the last follow-up, MacNab criteria were used to evaluate the clinical efficacy. Imaging evaluation included the measurement of intervertebral space height, lumbar physiological curvature, fusion rate and pedicle screw accuracy by preoperative and lateral X-ray films.

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other recruiting trials for Spinal Stenosis

Currently open trials in the same condition.

NCT07348419 — Quadro-Iliac vs Thoracolumbar Interfascial Plane Block for Analgesia After Single-Level Lumbar Disc Surgery · NA · recruiting
NCT06233617 — Dexamethasone vs. Dexmedetomidine for ESPB in Pain Management After Spine Surgery · Phase 4 · recruiting
NCT06950853 — ESCAPE : Evaluation of Spinal Conservation by Endoscopic Procedures to Avoid Fusion · recruiting
NCT06120231 — Pulse-Width Modulation · NA · recruiting
NCT06140927 — Effect of Ketamine on Intraoperative Motor Evoked Potentials · Phase 3 · recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT06290908 (US National Library of Medicine, public domain)
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Wen-xi Sun
Last refreshed: 4 March 2024

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT06290908.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing